The fluoroquinolone WIN 57273 showed identical bactericidal activities (MBC for 90%v of the strains = 0.25 ug/ml) for bacteremic strains ofEnterococcusfaecalis with and without high-level gentamicin resistance. WIN 57273 was bactericidal in time-kill measurements with highly gentamicin-resistant, ciprofloxacin-susceptible strains of E. faecalis. However, WIN 57273 was indifferent with penicillin for gentamicin-resistant E. faecalis and was not bactericidal for ciprofloxacin-resistant E. faecalis. antimicrobial agent which inhibits visible growth. The MBC is defined as the lowest concentration of antibiotic that kills .99.9% of the original inoculum. For our study, MBCs were determined by subculturing clear culture broths onto antibiotic-free Mueller-Hinton agar plates. Three E. faecalis strains were used for time-kill measurements: LS-31, which demonstrated high-level gentamicin resistance, high-level streptomycin resistance, and ciprofloxacin susceptibility (Gmr Smr Cips); LS-45, which demonstrated high-level gentamicin resistance, streptomycin susceptibility, and ciprofloxacin susceptibility (Gmr Sms Cips); and LS-49, which demonstrated high-level gentamicin resistance, streptomycin susceptibility, and ciprofloxacin resistance (Gmr Sm, Cipr). Time-kill measurements (10) were performed in triplicate with each strain to determine the extents and rates of killing by WIN 57273 alone or with penicillin and by penicillin with and without an aminoglycoside. Antibiotics were tested at the following concentrations: penicillin, 10 U/ml; WIN 57273, 2 jig/ml; gentamicin, 5 ,ug/ml; and streptomycin, 25 p,g/ml. Antibiotic carryover was eliminated by the use of a minimum dilution factor of at least 100. Organisms were diluted in 20 ml of cation-supplemented Mueller-Hinton broth to give a final inoculum of 5 x 105 CFU/ml and incubated with mechanical shaking at 35°C. At 0, 4, 8, and 24 h after inoculation, 0.5-ml samples were taken from the broth and passed through serial 10-fold dilutions. From each dilution, a 0.1-ml sample was spotted and spread over the entire surface of antibiotic-free agar. A 0.1-ml sample of undiluted broth was also directly inoculated to antibioticfree agar. Colonies were counted after 24 h of incubation. The minimum accurately countable bacterial population was 50 CFU/ml. Bactericidal activity in time-kill measurements is defined as a .3 log10 increase in bacterial killing at 24 h of incubation. Synergy is defined as a .2 logl0 increase in killing by a combination of two antibiotics compared with the killing by the active antibiotic alone, with the other antibiotic present in a concentration which does not affect the growth curve of the organism. If the result of using two drugs in time-kill measurements equals the effect of the more active antibiotic used alone (s1 loglo increase), the antibiotic combination is considered to be indifferent (2).
High-level gentamicin-resistant Enterococcus faecalis has emerged as an important pathogen in hospitals throughout the United States. In strains with high-level resistance, bactericidal synergy with a cell wall-active agent plus an aminoglycoside cannot be achieved. Synergy is important for patients with severe enterococcal infections such as endocarditis, osteomyelitis, and meningitis. The combination of ciprofloxacin with a penicillin when tested against enterococci has been indifferent for most strains (12) . Additionally, the widespread use of ciprofloxacin has resulted in resistance to this quinolone among gentamicin-resistant enterococci (16) . A number of novel fluoroquinolones, including WIN 57273 (6, 7, 17) , PD (10) were performed in triplicate with each strain to determine the extents and rates of killing by WIN 57273 alone or with penicillin and by penicillin with and without an aminoglycoside. Antibiotics were tested at the following concentrations: penicillin, 10 U/ml; WIN 57273, 2 jig/ml; gentamicin, 5 ,ug/ml; and streptomycin, 25 p,g/ml. Antibiotic carryover was eliminated by the use of a minimum dilution factor of at least 100. Organisms were diluted in 20 ml of cation-supplemented Mueller-Hinton broth to give a final inoculum of 5 x 105 CFU/ml and incubated with mechanical shaking at 35°C. At 0, 4, 8, and 24 h after inoculation, 0.5-ml samples were taken from the broth and passed through serial 10-fold dilutions. From each dilution, a 0.1-ml sample was spotted and spread over the entire surface of antibiotic-free agar. A 0.1-ml sample of undiluted broth was also directly inoculated to antibioticfree agar. Colonies were counted after 24 h of incubation. The minimum accurately countable bacterial population was 50 CFU/ml. Bactericidal activity in time-kill measurements is defined as a .3 log10 increase in bacterial killing at 24 h of incubation. Synergy is defined as a .2 logl0 increase in killing by a combination of two antibiotics compared with the killing by the active antibiotic alone, with the other antibiotic present in a concentration which does not affect the growth curve of the organism. If the result of using two drugs in time-kill measurements equals the effect of the more active antibiotic used alone (s1 loglo increase), the antibiotic combination is considered to be indifferent (2) .
The activity of WIN 57273 was compared with those of other fluoroquinolones, as shown in (MIC90) of gentamicin-resistant and gentamicin-susceptible strains and 16-to 32-fold more active on the basis of the MBC for 90% of the strains. There was no significant difference in activity between ciprofloxacin, ofloxacin, and temafloxacin. Of the 51 bacteremic strains tested, 4 were resistant to ciprofloxacin (MIC 2 4 ,ug/ml). Not surprisingly, all four ciprofloxacin-resistant isolates appeared after the addition of ciprofloxacin to our hospital formulary. These four strains were also resistant to ofloxacin and temafloxacin, although there was no prior use of these antibiotics at our medical center. Despite resistance to these fluoroquinolones, all four strains were inhibited by WIN 57273, with
MICs of 0.125, 0.125, 0.5, and 1 ,ug/ml, well below the preliminary susceptibility breakpoint of 2 ,ug/ml. When the ciprofloxacin-resistant strains are removed from our analysis, the MIC90 for both gentamicin-susceptible and gentamicin-resistant strains is 0.125 p,g/ml. This MIC90 is equivalent to that previously reported with WIN 57273 for ciprofloxacin-susceptible E. faecalis (7) and comparable with or below the MIC90s for other new fluoroquinolones (1, 5, 8, 15, 19) . Time-kill experiments were performed with three phenotypically distinct isolates. For LS-31 (Gmr Smr Cips), WIN 57273 (MIC and MBC of 0.03 ,ug/ml) alone was bactericidal, but the addition of penicillin did not increase the bactericidal action of WIN 57273 (indifference) (Fig. 1) . Neither gentamicin nor streptomycin demonstrated synergistic activity with penicillin for LS-31 (data not shown). WIN 57273 alone was also bactericidal for LS-45 (Gmr Sm5 Cips), but killing of this strain by WIN 57273 (MIC and MBC of 0.06 ,ug/ml) was not as rapid as with the combination of penicillin and streptomycin (Fig. 2) , and the addition of penicillin did not increase the killing of WIN 57273 alone. Finally, penicillin and streptomycin were rapidly bactericidal for LS-49 (Gmr SMs Cipr) but WIN 57273 (MIC and MBC of 0.125 ,ug/ml) alone was not bactericidal and the addition of WIN 57273 to penicillin had no effect (Fig. 3) . Gentamicin was not synergistic with penicillin for either E. faecalis LS-45 or LS-49 (data not shown).
A clinical response to a change from gentamicin to streptomycin in combination therapy of gentamicin-resistant, streptomycin-susceptible enterococcal infection has been previously described (18) . However, a high prevalence of E. faecalis blood culture isolates (ca. 50%) has been reported to be associated with high-level resistance to both gentamicin and streptomycin (13) . Several groups have investigated the activity of ciprofloxacin combined with a penicillin against the enterococci. In vitro measurements of ciprofloxacin combined with penicillin or azlocillin failed to show synergy against E. faecalis (9). In experimental endocarditis induced by using highly gentamicin-resistant E. faecalis, continuous infusion of ciprofloxacin combined with azlocillin resulted in statistically significant sterilization of blood cultures compared with that for untreated controls (3). However, the combination of ciprofloxacin and azlocillin was not more effective than ciprofloxacin alone (3). For two clinical strains of E. faecalis without high-level gentamicin resistance from patients with endocarditis, ciprofloxacin used in combination with penicillin was less effective therapy than penicillin alone in a rabbit endocarditis model (4 
